We are live on ! Find out more
GKIM

GW&K Investment Management Portfolio holdings

AUM $11.3B
1-Year Est. Return 31.98%
This Fund
S&P 500
This Quarter Est. Return
+6.23%
1 Year Est. Return
+31.98%
3 Year Est. Return
+79.76%
5 Year Est. Return
+101.81%
10 Year Est. Return
+512.72%
AUM
$11.5B
AUM Growth
+$638M
Cap. Flow
+$151M
Cap. Flow %
1.32%
Top 10 Hldgs %
11.1%
Holding
425
New
38
Increased
213
Reduced
112
Closed
11

Sector Composition

Rank Sector Weight
1 Healthcare 17.4%
2 Technology 16.59%
3 Consumer Discretionary 14.46%
4 Industrials 13.71%
5 Financials 13.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BFAM icon
76
Bright Horizons
BFAM
$3.76B
$52.5M 0.46%
356,969
+17,514
+5% +$2.62M
TCOM icon
77
Trip.com Group
TCOM
$29.1B
$52.5M 0.46%
1,479,465
-35,165
-2% -$1.34M
ABBV icon
78
AbbVie
ABBV
$442B
$52.4M 0.46%
465,573
-789
-0.2% -$88.9K
CGNX icon
79
Cognex
CGNX
$10.6B
$52.1M 0.45%
620,377
+10,064
+2% +$814K
BURL icon
80
Burlington
BURL
$22.6B
$50.5M 0.44%
156,987
+2,179
+1% +$694K
PGNY icon
81
Progyny
PGNY
$2.04B
$50.3M 0.44%
853,096
+5,364
+0.6% +$301K
ATR icon
82
AptarGroup
ATR
$8.57B
$50M 0.44%
355,218
+5,414
+2% +$798K
SUPN icon
83
Supernus Pharmaceuticals
SUPN
$2.73B
$49.8M 0.43%
1,616,100
+42,689
+3% +$1.31M
PATK icon
84
Patrick Industries
PATK
$2.81B
$49.7M 0.43%
1,021,968
+24,580
+2% +$1.41M
IART icon
85
Integra LifeSciences
IART
$1.35B
$49.6M 0.43%
726,682
+991
+0.1% +$70.1K
MOH icon
86
Molina Healthcare
MOH
$10.2B
$49.5M 0.43%
195,416
+3,363
+2% +$845K
PM icon
87
Philip Morris
PM
$290B
$49.5M 0.43%
498,944
-102
-0% -$9.79K
CHDN icon
88
Churchill Downs
CHDN
$6.18B
$49.4M 0.43%
498,134
+97,756
+24% +$10M
BIDU icon
89
Baidu
BIDU
$35.9B
$49.3M 0.43%
241,626
+81,893
+51% +$16.4M
CYRX icon
90
CryoPort
CYRX
$757M
$49.2M 0.43%
779,228
+91,057
+13% +$5.13M
CVCO icon
91
Cavco Industries
CVCO
$4.57B
$48.8M 0.42%
219,409
+3,693
+2% +$805K
BR icon
92
Broadridge
BR
$19.5B
$48.6M 0.42%
301,028
-254
-0.1% -$40.6K
RPM icon
93
RPM International
RPM
$14.9B
$48.3M 0.42%
544,643
+10,198
+2% +$949K
HALO icon
94
Halozyme
HALO
$11.6B
$48.3M 0.42%
1,063,194
+1,964
+0.2% +$86.9K
SBCF icon
95
Seacoast Banking Corp of Florida
SBCF
$3.42B
$48.3M 0.42%
1,413,188
+11,224
+0.8% +$409K
MZTI
96
The Marzetti Company
MZTI
$3.15B
$48.1M 0.42%
248,671
+4,750
+2% +$892K
JAZZ icon
97
Jazz Pharmaceuticals
JAZZ
$16.1B
$47.9M 0.42%
269,409
+3,962
+1% +$686K
VICI icon
98
VICI Properties
VICI
$28.6B
$46.9M 0.41%
1,511,418
-1,175
-0.1% -$36.4K
HPP
99
Hudson Pacific Properties
HPP
$724M
$46.8M 0.41%
240,439
+53,943
+29% +$10.7M
BCPC
100
Balchem Corp
BCPC
$5.71B
$46.7M 0.41%
356,077
-224
-0.1% -$28.8K

Similar funds

GW&K Investment Management's Q2 2021 Portfolio in Review

As of Q2 2021, GW&K Investment Management held 425 positions worth $11.5B, up 5.9% from $10.9B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

GW&K Investment Management's Q2 2021 filing shows 38 new, 213 increased, 112 reduced and 11 closed positions. Its largest new stake was Manhattan Associates: 258,950 shares worth $37.5M. The largest sale was TCF Financial Corporation Common Stock, an estimated $52.2M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

  • GW&K Investment Management's largest Q2 2021 buy was Manhattan Associates: 258,950 shares worth $37.5M.
  • GW&K Investment Management added most to Comfort Systems in Q2 2021, an estimated $32.7M increase.
  • GW&K Investment Management's biggest Q2 2021 reduction was Ecolab, cutting an estimated $28.4M.
  • GW&K Investment Management fully exited TCF Financial Corporation Common Stock in Q2 2021, selling an estimated $52.2M.
  • GW&K Investment Management's ten largest holdings make up 11% of its $11.5B portfolio in Q2 2021.
  • GW&K Investment Management opened 38 new positions and closed 11 in Q2 2021.
  • GW&K Investment Management's portfolio value rose 5.9% quarter-over-quarter to $11.5B.

Based on GW&K Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.